Petra Wicklandt Appointed Head of Corporate Affairs at Merck


Alternativ








Darmstadt, Germany, December 15, 2017
Merck, a leading science and technology company, today announced that Petra Wicklandt (53) will take over the leadership of the newly created Corporate Affairs unit as of January 1, 2018. She will report to Stefan Oschmann, Executive Board Chairman & CEO of Merck.


I am very pleased that Petra Wicklandt, an experienced executive from within the company, will represent Merck vis-à-vis politicians, associations and non- governmental organizations,” said Stefan Oschmann. Corporate Affairs consolidates the government and public affairs of the three business sectors as well as the Corporate Responsibility and Global Health activities of the Group. In the future, Corporate Affairs offices in Berlin, Brussels, Washington, Boston as well as Beijing and Shanghai will bolster Merck’s presence in the regions. The objectives of the new Group function are to provide even more efficient support to the businesses as they implement their objectives and to better steer Group-wide initiatives.

Petra Wicklandt joined Merck in 1994 and most recently served as Head of Global Chemical and Pharmaceutical Development. Her work focused on building a high- performance organization for the development of manufacturing methods and quality control for new active ingredients and dosage forms. Wicklandt studied pharmacy and earned a doctorate at the Johannes Gutenberg University of Mainz.

Contact:
Merck KGaA
Group Communications Performance Materials
Frankfurter Str. 250
64293 Darmstadt
www.merckgroup.com


About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

« back